Joint Formulary & PAD

Paliperidone - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Depot injection
Associated Icons :
SPC
Restrictions / Comments :
Important

Administration under the shared-care LCS when prescribed in Primary Care.

See shared-care document below

Documents :
 
 

Status 2

Red
Formulations :
  • Depot injection
Associated Icons :
SPC
Restrictions / Comments :
Important

Paliperidone palmitate - where there is no LCS in place, the prescribing responsibility remains with SABP.

Secondary Care may prescribe for in-patients (on the instruction of a SABP specialist) and prescribing continued by SABP after discharge.

 

Status 3

Non Formulary
Formulations :
  • Modified release tablets
Associated Icons :
NFD1
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Paliperidone
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
depot antipsychotics, LAI, long acting depot antipsychotics
Brand Names Include :
Xeplion (monthly), Trevicta (3-monthly), Byannli (6-monthly), Invega
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Paliperidone is used to treat.

  • No records returned.

Committee Recommendations (1)

The Surrey Heartlands APC recommends the administration of depot antipsychotic injections under an AMBER shared care agreement for practices that have signed up to the agreed locally commissioned service (LCS).
The updated shared care agreement can be found in "Documentation"

Surrey Heartlands ICB has developed the LCS to enable stable patients with schizophrenia to be prescribed and administered these injections through their primary care prescriber (GP). 

If a practice has not signed up to the LCS the drug remains as RED status and prescriptions will be issued by the provider.